← Eichor
Condition: Radiodermatitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Radiodermatitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Topical Diclofenac for Prevention of Radiation-induced Dermatitis
NA · 1 location(s) · The Second Affiliated Hospital of Hainan Medical University · NCT06905561
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06953245
Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury
Phase 1 · 2 location(s) · West China Hospital · NCT07635277
Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Pr
Phase 3 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06915857
ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head
NA · 1 location(s) · West China Hospital · NCT07081074
Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin
NA · 1 location(s) · Qianfoshan Hospital · NCT06837831
Topical Chlorhexidine Spray for the Prevention of Acute Radiation Dermatitis in Patients With Nasopharyngeal Carcinoma:
Phase 3 · 1 location(s) · Jiangxi Provincial Cancer Hospital · NCT07559877
Mepitel Film Breast
Phase N/A · 1 location(s) · National University Hospital, Singapore · NCT07729423
Dermatitis During Adjuvant Irradiation for BREAst Cancer:
NA · 5 location(s) · University Hospital Schleswig-Holstein · NCT06483477
Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
NA · 1 location(s) · University of the Philippines · NCT05079763
Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fracti
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT06729814
ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer
NA · 1 location(s) · West China Hospital · NCT07086638
Epidermal Skin Grafts to Improve Healing In Radiation Wounds
NA · 1 location(s) · Massachusetts General Hospital · NCT04560803
Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
NA · 1 location(s) · Ain Shams University · NCT07256119
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Phase 2/Phase 3 · 2 location(s) · West China Hospital · NCT07353671
The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients
Phase N/A · 1 location(s) · Fudan University · NCT05032768
Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer
Phase 3 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07066280
Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer
NA · 1 location(s) · West China Hospital · NCT07064577
Taurine's Therapeutic Effect on Acute Radiation-induced Oral Mucositis and Dermatitis
Phase 2 · 1 location(s) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao · NCT07029178
Polarized Light Therapy for Radiation Dermatitis in Breast Cancer
NA · 1 location(s) · Beni-Suef University · NCT07600957
StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
NA · 1 location(s) · National University Hospital, Singapore · NCT03394417
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.